Abstract

BackgroundMethylated resveratrol analogs show similar biological activities that are comparable with those of the resveratrol. However, the methylated resveratrol analogs exhibit better bioavailability as they are more easily transported into the cell and more resistant to degradation. Although these compounds are widely used in human health care and in industrial materials, at present they are mainly obtained by extraction from raw plant sources. Accordingly their production can suffer from a variety of economic problems, including low levels of productivity and/or heterogeneous quality. On this backdrop, large-scale production of plant metabolites via microbial approaches is a promising alternative to chemical synthesis and extraction from plant sources.ResultsAn Escherichia coli system containing an artificial biosynthetic pathway that produces methylated resveratrol analogues, such as pinostilbene (3,4’-dihydroxy-5-methoxystilbene), 3,5-dihydroxy-4’-methoxystilbene, 3,4’-dimethoxy-5-hydroxystilbene, and 3,5,4’-trimethoxystilbene, from simple carbon sources is developed. These artificial biosynthetic pathways contain a series of codon-optimized O-methyltransferase genes from sorghum in addition to the resveratrol biosynthetic genes. The E. coli cells that harbor pET-opTLO1S or pET-opTLO3S produce the one-methyl resveratrol analogues of 3,5-dihydroxy-4’-methoxystilbene and pinostilbene, respectively. Furthermore, the E. coli cells that harbor pET-opTLO13S produce 3,5-dihydroxy-4’-methoxystilbene, bis-methyl resveratrol (3,4’-dimethoxy-5-hydroxystilbene), and tri-methyl resveratrol (3,5,4’-trimethoxystilbene).ConclusionsOur strategy demonstrates the first harness microorganisms for de novo synthesis of methylated resveratrol analogs used a single vector system joined with resveratrol biosynthetic genes and sorghum two resveratrol O-methyltransferase genes. Thus, this is also the first report on the production of the methylated resveratrol compounds bis-methyl and tri-methyl resveratrol (3,4’-dimethoxy-5-hydroxystilbene and 3,5,4’-trimethoxystilbene) in the E. coli culture. Thus, the production of the methylated resveratrol compounds was performed on the simple E. coli medium without precursor feeding in the culture.

Highlights

  • Methylated resveratrol analogs show similar biological activities that are comparable with those of the resveratrol

  • Characterization of the resveratrol O-methyltransferase via a bioconversion experiment in recombinant E. coli Previous reports have noted that the two resveratrol O-methyltransferase genes from Sorghum bicolor are capable of using resveratrol as a substrate that yields methylated analogs of resveratrol [12,13]

  • In order to investigate whether the recombinant O-methyltransferases can catalyze the production of methylated resveratrol derivatives, resveratrol was added to the cultured recombinant E. coli harboring pET22-sbCOM1 and pET22-sbCOM3

Read more

Summary

Introduction

Methylated resveratrol analogs show similar biological activities that are comparable with those of the resveratrol. The methylated resveratrol analogs exhibit better bioavailability as they are more transported into the cell and more resistant to degradation These compounds are widely used in human health care and in industrial materials, at present they are mainly obtained by extraction from raw plant sources. Their production can suffer from a variety of economic problems, including low levels of productivity and/or heterogeneous quality. The substitution of the hydroxy with the methoxy groups increases the lipophilicity of pterostilbene over the resveratrol, which results in high bioavailability These differences in the pharmacokinetics might explain the higher biological activity of pterostilbene over its parental compound resveratrol [9]. Methylated resveratrols have become an attractive target for bioengineering, but few attempts to characterize the methylation enzyme of resveratrol have been reported far [12,13,14,15,16,17]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call